vs
阿普塔集团（ATR）与百时美施贵宝（MYE）财务数据对比。点击上方公司名可切换其他公司
阿普塔集团的季度营收约是百时美施贵宝的4.7倍（$962.7M vs $204.0M）。阿普塔集团净利率更高（7.7% vs 5.6%，领先2.2%）。阿普塔集团同比增速更快（13.5% vs 0.0%）。阿普塔集团自由现金流更多（$96.9M vs $18.9M）。过去两年阿普塔集团的营收复合增速更高（2.6% vs -0.8%）
阿普塔集团（AptarGroup, Inc.）是总部位于美国的全球性制造企业，主营消费品分配包装产品及药物给药装置的研发与生产，目前在全球18个国家设有生产运营基地，服务医药、快消等多领域客户。
百时美施贵宝是一家总部位于美国新泽西州普林斯顿的跨国制药企业，核心产品覆盖多个疾病领域，包括用于房颤治疗的阿哌沙班（商品名艾乐妥）、多种癌症适应症的纳武利尤单抗（商品名欧狄沃）、用于多发性骨髓瘤等病症的来那度胺（商品名瑞复美）等。
ATR vs MYE — 直观对比
营收规模更大
ATR
是对方的4.7倍
$204.0M
营收增速更快
ATR
高出13.5%
0.0%
净利率更高
ATR
高出2.2%
5.6%
自由现金流更多
ATR
多$77.9M
$18.9M
两年增速更快
ATR
近两年复合增速
-0.8%
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $962.7M | $204.0M |
| 净利润 | $74.3M | $11.3M |
| 毛利率 | — | 33.2% |
| 营业利润率 | 11.0% | 9.9% |
| 净利率 | 7.7% | 5.6% |
| 营收同比 | 13.5% | 0.0% |
| 净利润同比 | -26.4% | 163.7% |
| 每股收益（稀释后） | $1.13 | $0.30 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ATRMYE
| Q4 25 | $962.7M | $204.0M | ||
| Q3 25 | $961.1M | $205.4M | ||
| Q2 25 | $966.0M | $209.6M | ||
| Q1 25 | $887.3M | $206.8M | ||
| Q4 24 | $848.1M | $203.9M | ||
| Q3 24 | $909.3M | $205.1M | ||
| Q2 24 | $910.1M | $220.2M | ||
| Q1 24 | $915.4M | $207.1M |
净利润ATRMYE
| Q4 25 | $74.3M | $11.3M | ||
| Q3 25 | $127.9M | $7.1M | ||
| Q2 25 | $111.7M | $9.7M | ||
| Q1 25 | $78.8M | $6.8M | ||
| Q4 24 | $100.9M | $4.3M | ||
| Q3 24 | $100.0M | $-10.9M | ||
| Q2 24 | $90.5M | $10.3M | ||
| Q1 24 | $83.1M | $3.5M |
毛利率ATRMYE
| Q4 25 | — | 33.2% | ||
| Q3 25 | — | 33.4% | ||
| Q2 25 | — | 33.7% | ||
| Q1 25 | — | 33.4% | ||
| Q4 24 | — | 32.3% | ||
| Q3 24 | — | 31.8% | ||
| Q2 24 | — | 34.3% | ||
| Q1 24 | — | 31.0% |
营业利润率ATRMYE
| Q4 25 | 11.0% | 9.9% | ||
| Q3 25 | 14.2% | 8.6% | ||
| Q2 25 | 14.9% | 9.5% | ||
| Q1 25 | 12.8% | 8.1% | ||
| Q4 24 | 14.2% | 7.2% | ||
| Q3 24 | 15.2% | -2.3% | ||
| Q2 24 | 13.8% | 10.8% | ||
| Q1 24 | 12.2% | 5.3% |
净利率ATRMYE
| Q4 25 | 7.7% | 5.6% | ||
| Q3 25 | 13.3% | 3.5% | ||
| Q2 25 | 11.6% | 4.6% | ||
| Q1 25 | 8.9% | 3.3% | ||
| Q4 24 | 11.9% | 2.1% | ||
| Q3 24 | 11.0% | -5.3% | ||
| Q2 24 | 9.9% | 4.7% | ||
| Q1 24 | 9.1% | 1.7% |
每股收益（稀释后）ATRMYE
| Q4 25 | $1.13 | $0.30 | ||
| Q3 25 | $1.92 | $0.19 | ||
| Q2 25 | $1.67 | $0.26 | ||
| Q1 25 | $1.17 | $0.18 | ||
| Q4 24 | $1.48 | $0.11 | ||
| Q3 24 | $1.48 | $-0.29 | ||
| Q2 24 | $1.34 | $0.28 | ||
| Q1 24 | $1.23 | $0.09 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $409.5M | $45.0M |
| 总债务越低越好 | $1.1B | $345.8M |
| 股东权益账面价值 | $2.7B | $294.2M |
| 总资产 | $5.3B | $851.3M |
| 负债/权益比越低杠杆越低 | 0.43× | 1.18× |
8季度趋势，按日历期对齐
现金及短期投资ATRMYE
| Q4 25 | $409.5M | $45.0M | ||
| Q3 25 | $264.8M | $48.0M | ||
| Q2 25 | $169.8M | $41.3M | ||
| Q1 25 | $136.8M | $35.3M | ||
| Q4 24 | $226.2M | $32.2M | ||
| Q3 24 | $327.9M | $29.7M | ||
| Q2 24 | $223.9M | $37.3M | ||
| Q1 24 | $201.1M | $32.7M |
总债务ATRMYE
| Q4 25 | $1.1B | $345.8M | ||
| Q3 25 | $546.0M | $361.2M | ||
| Q2 25 | $535.1M | $370.8M | ||
| Q1 25 | $561.2M | $383.4M | ||
| Q4 24 | $688.1M | $375.0M | ||
| Q3 24 | $822.7M | $387.5M | ||
| Q2 24 | $681.5M | $400.1M | ||
| Q1 24 | $680.4M | $400.6M |
股东权益ATRMYE
| Q4 25 | $2.7B | $294.2M | ||
| Q3 25 | $2.8B | $286.6M | ||
| Q2 25 | $2.7B | $284.6M | ||
| Q1 25 | $2.5B | $277.4M | ||
| Q4 24 | $2.5B | $277.5M | ||
| Q3 24 | $2.5B | $275.6M | ||
| Q2 24 | $2.4B | $294.6M | ||
| Q1 24 | $2.3B | $291.7M |
总资产ATRMYE
| Q4 25 | $5.3B | $851.3M | ||
| Q3 25 | $5.1B | $864.1M | ||
| Q2 25 | $4.9B | $862.7M | ||
| Q1 25 | $4.5B | $883.8M | ||
| Q4 24 | $4.4B | $860.8M | ||
| Q3 24 | $4.6B | $905.0M | ||
| Q2 24 | $4.5B | $951.6M | ||
| Q1 24 | $4.4B | $947.1M |
负债/权益比ATRMYE
| Q4 25 | 0.43× | 1.18× | ||
| Q3 25 | 0.20× | 1.26× | ||
| Q2 25 | 0.20× | 1.30× | ||
| Q1 25 | 0.22× | 1.38× | ||
| Q4 24 | 0.28× | 1.35× | ||
| Q3 24 | 0.32× | 1.41× | ||
| Q2 24 | 0.28× | 1.36× | ||
| Q1 24 | 0.29× | 1.37× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $183.7M | $22.6M |
| 自由现金流经营现金流 - 资本支出 | $96.9M | $18.9M |
| 自由现金流率自由现金流/营收 | 10.1% | 9.3% |
| 资本支出强度资本支出/营收 | 9.0% | 1.8% |
| 现金转化率经营现金流/净利润 | 2.47× | 1.99× |
| 过去12个月自由现金流最近4个季度 | $299.6M | $67.2M |
8季度趋势，按日历期对齐
经营现金流ATRMYE
| Q4 25 | $183.7M | $22.6M | ||
| Q3 25 | $177.6M | $25.8M | ||
| Q2 25 | $126.0M | $28.3M | ||
| Q1 25 | $82.7M | $10.1M | ||
| Q4 24 | $178.2M | $27.3M | ||
| Q3 24 | $229.3M | $17.3M | ||
| Q2 24 | $143.6M | $14.3M | ||
| Q1 24 | $92.3M | $20.3M |
自由现金流ATRMYE
| Q4 25 | $96.9M | $18.9M | ||
| Q3 25 | $114.3M | $21.5M | ||
| Q2 25 | $62.5M | $24.7M | ||
| Q1 25 | $25.9M | $2.0M | ||
| Q4 24 | $112.2M | $20.2M | ||
| Q3 24 | $162.7M | $10.1M | ||
| Q2 24 | $75.4M | $9.9M | ||
| Q1 24 | $16.7M | $14.6M |
自由现金流率ATRMYE
| Q4 25 | 10.1% | 9.3% | ||
| Q3 25 | 11.9% | 10.5% | ||
| Q2 25 | 6.5% | 11.8% | ||
| Q1 25 | 2.9% | 1.0% | ||
| Q4 24 | 13.2% | 9.9% | ||
| Q3 24 | 17.9% | 4.9% | ||
| Q2 24 | 8.3% | 4.5% | ||
| Q1 24 | 1.8% | 7.0% |
资本支出强度ATRMYE
| Q4 25 | 9.0% | 1.8% | ||
| Q3 25 | 6.6% | 2.1% | ||
| Q2 25 | 6.6% | 1.7% | ||
| Q1 25 | 6.4% | 3.9% | ||
| Q4 24 | 7.8% | 3.5% | ||
| Q3 24 | 7.3% | 3.5% | ||
| Q2 24 | 7.5% | 2.0% | ||
| Q1 24 | 8.3% | 2.8% |
现金转化率ATRMYE
| Q4 25 | 2.47× | 1.99× | ||
| Q3 25 | 1.39× | 3.63× | ||
| Q2 25 | 1.13× | 2.92× | ||
| Q1 25 | 1.05× | 1.49× | ||
| Q4 24 | 1.77× | 6.36× | ||
| Q3 24 | 2.29× | — | ||
| Q2 24 | 1.59× | 1.40× | ||
| Q1 24 | 1.11× | 5.79× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ATR
暂无分部数据
MYE
| Industrial | $64.3M | 32% |
| Auto Aftermarket | $51.7M | 25% |
| Infrastructure | $34.0M | 17% |
| Food And Beverage | $23.2M | 11% |
| Vehicle | $17.9M | 9% |
| Consumer | $12.9M | 6% |
